In a spirit of solidarity and camaraderie, Genoma has gathered his team Sunday 23 of October to participate to the Pink Ribbon Challenge in Thonon-les Bains, an attractive lake-side town situated in the Rhone Alpes region.
The idea is to do good to your body through a physical activity adapted to the pace of each one in order to raise awareness of early detection of breast cancer.
The goal of this event is to spread a preventive message and inform that screening is a key in the fight against breast cancer.
If identified at an early stage, breast cancer can be cured in more than 90% of cases, and also be treated with less aggressive therapy.
The leading scientists advocate for BRCA1 and BRCA2 genetic screening for every woman at about 30 as a part of routine medical care.
Early detection of actionable mutations is vital for cancer prevention.
BRCA1 and BRCA2 (Breast Cancer 1 and 2) are tumor suppressor genes that help to ensure the stability of the cell’s genetic material. When either of these genes undergoes a mutation, DNA damage cannot be repaired properly, and cells are more likely to develop additional genetic alterations resulting in cancer.
Knowing this in advance, appropriate action can be taken to preserve your health.
On all the pink t-shirts of the Genoma team is written “Serenity”: this is not only a message of care and solidarity, but also the name of a genetic screening test that can be used for women of any age to detect mutations of BRCA1 and BRCA2 genes.
If you are interested in this hereditary breast and ovarian cancer screening, please click here.